Oxytocin: A Shield against Radiation-Induced Lung Injury in Rats
Tomography · 2024
DOI: 10.3390/tomography10090101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2024. Verfasst von Ahmet Kayalı und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Çelebi University, 35620 Izmir, Türkiye. Hauptthemen laut MEDLINE: Oxytocin, Rats, Wistar. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Radiation-induced lung injury (RILI), a serious side effect of thoracic radiotherapy, can lead to acute radiation pneumonitis (RP) and chronic pulmonary fibrosis (PF). Despite various interventions, no effective protocol exists to prevent pneumonitis. Oxytocin (OT), known for its anti-inflammatory, antiapoptotic, and antioxidant properties, has not been explored for its potential in mitigating RILI. Materials and Methods: This study involved 24 female Wistar albino rats, divided into three groups: control group, radiation (RAD) + saline, and RAD + OT. The RAD groups received 18 Gy of whole-thorax irradiation. The RAD + OT group was treated with OT (0.1 mg/kg/day) intraperitoneally for 16 weeks. Computerizing tomography (CT) imaging and histopathological, biochemical, and blood gas analyses were performed to assess lung tissue damage and inflammation.
Results
Histopathological examination showed significant reduction in alveolar wall thickening, inflammation, and vascular changes in the RAD + OT group compared to the RAD + saline group. Biochemical analysis revealed decreased levels of TGF-beta, VEGF, and PDGF, and increased BMP-7 and prostacyclin in the RAD + oxytocin group (p < 0.05). Morphometric analysis indicated significant reductions in fibrosis, edema, and immune cell infiltration. CT imaging demonstrated near-normal lung parenchyma density in the RAD + oxytocin group (p < 0.001).
Conclusion
Oxytocin administration significantly mitigates radiation-induced pneumonitis in rats, implying that is has potential as a therapeutic agent for preventing and treating RILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Çelebi University, 35620 Izmir, Türkiye.
- Department of Pediatrics, Istanbul Taksim Research and Training Hospital, 34433 Istanbul, Türkiye.
- Department of Histology and Embryology, Faculty of Medicine, Ege University, 35030 Izmir, Türkiye.
- Department of Radiation Oncology, Giresun Training and Research Hospital, 28100 Giresun, Türkiye.
- Department of Physiology, Faculty of Medicine, Demiroğlu Bilim University, 34394 Istanbul, Türkiye.
ORCID-Profile: Ahmet Kayalı, Ejder Saylav Bora, Yiğit Uyanikgil, Özüm Atasoy
Zitieren
APA
Kayalı, A., Arda, D. B., Bora, E. S., Uyanikgil, Y., Atasoy, Ö., & Erbaş, O. (2024). Oxytocin: A Shield against Radiation-Induced Lung Injury in Rats. Tomography. https://doi.org/10.3390/tomography10090101
Vancouver
Kayalı A, Arda DB, Bora ES, Uyanikgil Y, Atasoy Ö, Erbaş O. Oxytocin: A Shield against Radiation-Induced Lung Injury in Rats. Tomography. 2024. doi:10.3390/tomography10090101
BibTeX
@article{Kayal2024,
author = {Kayalı, Ahmet and Arda, Duygu Burcu and Bora, Ejder Saylav and Uyanikgil, Yiğit and Atasoy, Özüm and Erbaş, Oytun},
title = {Oxytocin: A Shield against Radiation-Induced Lung Injury in Rats},
journal = {Tomography},
year = {2024},
doi = {10.3390/tomography10090101}
}
EUVIMED